Salanersen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Salanersen, covering 2026-01-15 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec [Phase 3]